A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment

Clinical trial NCT07165015 · COMPLETED

Trial details

NCT number: NCT07165015
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment Healthy Renal Insufficiency End Stage Renal Disease (ESRD)

Start date: 2025-09-18
Primary completion: 2026-04-16
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.